▁Chron 10.375
ic 5.49609375
▁p 8.953125
ani 10.2734375
▁is 5.28125
▁still 6.06640625
▁considered 7.09375
▁to 1.84765625
▁be 0.54150390625
▁an 3.501953125
▁extreme 6.75390625
▁issue 8.9140625
▁among 7.28125
▁at 7.109375
▁least 2.15625
▁ 2.45703125
8 3.0859375
% 4.14453125
▁of 1.9443359375
▁the 1.5166015625
▁residents 8.3359375
▁of 2.404296875
▁progress 9.7265625
ive 1.16015625
▁countries 8.0078125
. 2.328125
▁The 2.572265625
▁introduction 7.15234375
▁of 0.28173828125
▁the 1.58203125
▁study 7.09765625
▁describes 7.9140625
▁the 0.8515625
▁apparent 9.40625
▁link 6.6484375
▁between 0.56982421875
▁pain 7.921875
▁and 0.9951171875
▁dem 8.546875
oral 3.38671875
ization 0.342041015625
. 1.5703125
▁Chron 6.328125
ic 0.064697265625
▁pain 0.44287109375
▁is 1.35546875
▁always 6.30859375
▁accompanied 1.6220703125
▁by 0.0465087890625
▁negative 4.765625
▁emot 1.3046875
ional 1.3486328125
▁experiences 2.85546875
▁and 2.158203125
▁blocks 11.3359375
▁a 4.14453125
▁t 8.1171875
pes 15.90625
ron 12.1015625
’ 21.34375
s 4.79296875
▁ability 6.40625
▁to 0.121337890625
▁receive 6.28515625
▁joy 5.7734375
▁and 1.5078125
▁sh 9.8828125
atisf 10.3671875
action 0.440185546875
▁from 2.0078125
▁life 2.31640625
. 0.412841796875
▁The 1.9560546875
▁research 3.8828125
▁investig 5.28515625
ates 0.495361328125
▁the 0.52880859375
▁development 6.1015625
▁of 0.2294921875
▁de 4.4296875
pression 0.2200927734375
▁and 1.181640625
▁an 5.0390625
q 9.84375
x 2.65234375
iety 0.8828125
▁among 2.78515625
▁patients 2.35546875
▁receiving 4.26171875
▁ph 5.953125
arma 2.3515625
ce 0.055084228515625
ut 0.0242462158203125
ical 0.0213775634765625
▁op 4.34375
io 0.293701171875
ids 0.6357421875
▁and 2.3828125
▁medical 6.36328125
▁mar 1.8486328125
iju 0.2413330078125
ana 0.0105438232421875
▁( 4.421875
MM 1.33984375
) 3.111328125
▁as 2.767578125
▁severe 9.8515625
▁pain 1.4375
kill 3.501953125
ers 0.01229095458984375
. 0.52001953125
▁It 3.28125
▁comp 5.19921875
ares 0.054901123046875
▁the 0.7060546875
▁effic 6.4296875
acy 0.036346435546875
▁of 0.287353515625
▁pres 4.94921875
cri 2.35546875
ptions 0.9013671875
▁and 2.169921875
▁exam 6.40625
ines 0.01971435546875
▁the 0.4755859375
▁possibility 4.125
P 12.5
▁of 3.10546875
▁post 7.71875
- 1.212890625
tre 2.734375
at 0.0352783203125
ent 6.3515625
▁de 2.4296875
pression 0.11090087890625
. 2.12109375
<0x0A> 2.65234375
There 4.91015625
▁is 1.0078125
▁currently 4.40625
▁a 1.2529296875
▁severe 5.07421875
▁lack 2.9921875
▁of 0.037017822265625
▁information 2.19921875
▁about 1.412109375
▁the 0.51025390625
▁effects 2.849609375
▁of 0.0875244140625
▁op 1.9443359375
i 3.533203125
ates 0.431640625
. 3.77734375
▁They 5.05859375
▁manage 9.1796875
▁pain 3.470703125
▁successfully 5.5
, 1.1591796875
▁but 0.34716796875
▁the 2.71484375
▁past 9.359375
▁few 2.2109375
▁dec 0.931640625
ades 0.001735687255859375
▁ind 11.0703125
ica 3.626953125
et 3.8359375
d 6.95703125
▁the 2.859375
▁growing 4.85546875
▁concern 3.470703125
▁regarding 4.09375
▁op 3.369140625
iate 0.595703125
▁ab 1.591796875
use 0.0149078369140625
▁in 3.31640625
▁forms 10.3984375
▁of 0.62451171875
▁over 3.29296875
d 0.400634765625
ose 0.231201171875
▁and 0.6875
▁add 1.216796875
iction 0.0458984375
. 0.22607421875
▁A 3.91796875
▁more 5.52734375
▁man 10.265625
ag 2.349609375
Re 12.25
able 5.37890625
▁and 2.482421875
▁sa 3.51953125
fer 0.06817626953125
▁alternative 2.794921875
▁might 6.2578125
▁eb 13.0390625
▁medical 3.029296875
▁mar 0.182373046875
iju 0.1005859375
ana 0.041900634765625
. 1.48046875
▁However 3.423828125
, 0.022247314453125
▁ta 11.5625
he 2.84765625
▁legal 4.48046875
▁status 1.5537109375
▁and 2.828125
▁novel 9.1875
ty 1.482421875
▁of 0.306640625
▁this 1.802734375
▁drug 2.234375
▁do 4.9140625
▁not 0.267822265625
▁allow 1.2724609375
▁finding 9.046875
a 6.4765625
▁large 3.734375
▁number 1.568359375
▁of 0.0302276611328125
▁studies 1.505859375
▁on 1.4833984375
▁its 1.1259765625
▁effect 2.49609375
iveness 0.4638671875
. 1.12109375
▁Specific 9.390625
l 8.9296875
aly 5.078125
, 0.37109375
▁it 2.673828125
▁concerns 6.0
▁the 0.71728515625
▁emot 7.79296875
ional 0.0292205810546875
▁condition 5.703125
▁of 0.47607421875
▁patients 0.61865234375
▁experien 6.3671875
cing 0.018646240234375
▁chron 1.7060546875
ic 0.0228271484375
▁pain 0.12298583984375
. 0.81103515625
▁This 3.240234375
▁research 2.94921875
▁paper 6.66015625
▁a 2.0703125
ims 0.013214111328125
▁to 0.261474609375
▁analyze 3.396484375
▁levels 9.3671875
▁of 0.057373046875
▁de 0.767578125
pression 0.0384521484375
▁and 0.272216796875
▁anx 0.373046875
iety 0.0148773193359375
▁among 0.72509765625
▁people 3.91796875
▁receiving 0.8486328125
▁ther 7.76953125
apy 0.331298828125
▁by 4.9375
▁comparing 8.9296875
▁the 1.171875
▁effects 2.0625
▁of 0.04290771484375
▁ph 2.92578125
arma 0.146484375
ce 0.00724029541015625
X 14.4375
ut 1.5048828125
ical 0.265625
▁op 0.50439453125
io 0.206787109375
ids 0.1500244140625
▁and 0.305908203125
▁MM 1.958984375
. 1.056640625
<0x0A> 1.4326171875
The 1.470703125
▁study 2.3671875
▁was 2.4765625
▁conducted 0.89501953125
▁in 1.5712890625
▁the 1.43359375
▁form 2.921875
▁of 0.04815673828125
▁o 9.8828125
cl 6.65625
lect 5.83203125
io 6.5390625
Z 6.9140625
n 1.6875
▁and 2.701171875
▁analysis 4.02734375
▁of 0.31689453125
▁statistical 4.83984375
▁data 0.33837890625
. 0.62060546875
▁Part 5.140625
icip 0.140625
ants 0.05218505859375
▁were 0.765625
▁rec 3.341796875
ru 0.1639404296875
ited 0.0188446044921875
▁for 4.3125
▁six 7.51171875
▁months 0.5986328125
▁at 3.654296875
▁two 2.6953125
▁major 6.12109375
▁pain 2.791015625
▁relief 5.05078125
▁cent 1.2119140625
ers 0.127685546875
▁in 0.71044921875
▁Israel 4.6875
. 0.396240234375
▁Te 9.40625
h 2.94140625
▁research 2.271484375
ers 1.2060546875
▁used 3.0234375
▁The 6.92578125
▁De 3.958984375
pression 0.030487060546875
▁Module 10.3671875
▁of 1.1884765625
▁the 0.369140625
▁Pat 2.48046875
ient 0.0199127197265625
▁Health 0.10675048828125
▁Question 0.042816162109375
naire 0.056732177734375
▁and 3.041015625
▁the 0.8369140625
▁General 2.416015625
ized 0.73681640625
▁An 0.0260009765625
x 0.013153076171875
iety 0.00887298583984375
▁Dis 0.73291015625
order 0.050628662109375
▁Sc 1.177734375
ale 0.12158203125
▁to 1.7509765625
▁interview 7.23046875
▁participants 2.03125
, 3.529296875
▁evaluate 5.86328125
▁their 0.82080078125
▁answers 6.65234375
, 1.1708984375
▁and 0.2432861328125
▁conduct 4.44921875
▁the 2.2109375
▁study 2.693359375
. 0.2310791015625
▁To 5.58984375
▁specifically 10.1953125
▁evaluate 2.650390625
▁and 4.359375
▁compare 0.98095703125
▁the 0.37646484375
▁prob 10.9609375
abilities 0.8642578125
▁of 0.154296875
▁de 0.82373046875
pression 0.041595458984375
▁or 4.671875
▁anx 0.163330078125
iety 0.00730133056640625
▁among 1.5859375
▁the 2.375
▁diverse 8.984375
▁groups 1.8154296875
, 1.494140625
▁the 1.0615234375
▁study 2.736328125
▁used 1.55859375
▁multiple 4.50390625
▁log 2.873046875
istic 0.06402587890625
▁regression 0.1253662109375
▁analysis 0.64404296875
▁and 2.458984375
▁chose 8.7578125
▁medical 7.46875
▁mar 0.455322265625
iju 0.048858642578125
ana 0.01666259765625
▁as 0.74072265625
▁the 1.1123046875
▁control 2.8046875
▁group 0.51806640625
. 0.31201171875
<0x0A> 0.9892578125
This 3.53515625
▁type 6.35546875
▁of 0.03045654296875
▁study 1.91015625
▁is 1.2060546875
▁the 3.310546875
▁most 1.875
▁reve 8.9296875
aling 0.06463623046875
▁and 1.0322265625
▁inclus 6.71875
ive 0.0204620361328125
, 2.203125
▁as 1.9697265625
▁it 0.347412109375
▁contains 4.98046875
▁direct 6.58984375
▁resp 12.640625
ness 11.9453125
▁from 2.736328125
▁a 3.6015625
▁large 2.275390625
▁number 0.61328125
▁of 0.01715087890625
▁participants 1.6845703125
. 0.78955078125
▁All 4.60546875
▁tools 9.21875
▁in 4.64453125
▁the 0.6787109375
▁form 3.681640625
▁of 0.05670166015625
▁question 2.31640625
na 0.058013916015625
ires 0.01016998291015625
▁and 2.068359375
▁scales 3.74609375
▁have 3.83984375
▁already 4.76171875
▁been 0.1431884765625
▁used 1.7451171875
▁and 2.07421875
▁proved 4.31640625
▁their 2.01171875
▁effic 3.068359375
acy 0.00775909423828125
▁for 3.650390625
▁collect 5.9609375
ing 0.04510498046875
▁analyt 8.1953125
ical 0.38720703125
▁data 0.267333984375
. 0.457275390625
▁It 3.32421875
▁helps 4.8046875
▁to 0.86328125
▁system 7.48828125
at 1.02734375
ize 0.07257080078125
▁and 1.6015625
▁class 4.1796875
ify 0.0299835205078125
▁distinct 9.453125
▁kinds 6.16796875
▁of 0.032440185546875
▁information 3.884765625
▁for 3.927734375
▁subsequent 4.6640625
▁un 7.80078125
comp 6.00390625
licated 0.1484375
▁services 11.421875
. 0.69921875
▁Thus 4.39453125
, 0.047882080078125
▁research 4.66015625
ers 0.54345703125
▁can 1.3212890625
▁compare 3.96875
▁the 1.068359375
▁effects 3.029296875
▁of 0.1126708984375
▁me 11.328125
ica 8.59375
it 8.6640625
ons 3.623046875
▁on 1.38671875
▁patients 2.193359375
▁of 4.3828125
▁diverse 4.26171875
▁age 2.490234375
▁groups 0.74267578125
, 0.8701171875
▁background 5.125
s 0.272216796875
, 0.1060791015625
▁physical 5.59375
▁conditions 1.43359375
, 0.13427734375
▁emot 5.42578125
ional 0.0889892578125
▁states 1.390625
, 0.15087890625
▁and 0.509765625
▁so 3.427734375
▁on 0.29443359375
. 0.0980224609375
<0x0A> 0.8388671875
The 1.234375
▁analysis 4.48828125
▁of 0.533203125
▁any 8.4609375
▁human 5.95703125
▁Bre 14.2265625
action 6.55859375
▁has 4.0625
▁a 1.9345703125
▁high 4.26953125
▁potential 3.3828125
▁of 1.4169921875
▁subject 5.8046875
iveness 3.78515625
▁and 1.3828125
▁bias 2.525390625
, 1.703125
▁especially 2.96875
▁regarding 4.7578125
▁people 4.9609375
▁in 4.03125
▁severe 5.0234375
▁pain 0.281494140625
▁and 2.45703125
▁un 5.2890625
stable 1.841796875
▁mot 9.9296875
ional 4.41796875
▁condition 3.08203125
. 0.144287109375
▁Perhaps 8.734375
▁some 5.30078125
▁patients 2.22265625
▁tend 6.140625
▁to 0.04620361328125
▁ex 2.564453125
agger 0.0180511474609375
ate 0.0205535888671875
▁their 0.7392578125
▁de 4.9765625
press 1.7255859375
ive 0.626953125
▁state 2.90234375
▁or 1.9208984375
▁vice 7.21484375
▁vers 0.1451416015625
a 0.0195465087890625
, 1.1318359375
▁de 7.328125
- 5.09765625
emph 1.2021484375
as 0.0296173095703125
ize 0.270751953125
▁serious 6.72265625
▁difficulties 6.05078125
. 0.935546875
▁Because 6.12109375
▁the 2.37890625
▁survey 6.25390625
▁responses 7.5390625
▁were 1.42578125
▁thoroughly 8.328125
▁anonymous 4.7265625
, 0.44189453125
▁the 1.54296875
▁research 1.4580078125
ers 0.254638671875
w 9.2109375
ere 0.06085205078125
▁unable 2.06640625
▁to 0.115966796875
▁carefully 8.4375
▁analyze 1.5595703125
▁each 3.998046875
▁patient 2.265625
’ 25.15625
s 1.029296875
▁reaction 4.51953125
▁and 2.51953125
▁compare 3.650390625
▁it 0.978515625
▁to 1.193359375
▁the 0.8076171875
▁actual 5.30078125
▁states 7.1953125
▁of 0.71923828125
▁condition 7.37890625
. 0.38427734375
▁o 10.2265625
M 5.35546875
re 7.23046875
▁accurate 4.51953125
▁answers 4.9296875
▁could 2.36328125
▁be 0.70068359375
▁obtained 0.91650390625
▁by 1.4697265625
▁professional 7.64453125
▁psych 2.451171875
olog 0.395263671875
ists 0.0269012451171875
▁via 7.55078125
▁personal 3.748046875
▁communication 4.70703125
▁and 1.9111328125
▁behavior 7.5625
al 0.339111328125
▁analysis 2.171875
. 0.2734375
▁However 2.802734375
, 0.00678253173828125
▁this 2.052734375
▁method 2.8671875
▁f 10.0546875
O 5.875
o 4.30859375
▁research 8.1171875
▁is 1.8408203125
▁way 8.0234375
▁more 1.6416015625
▁resource 6.72265625
- 0.65185546875
int 0.6455078125
ensive 0.0112152099609375
▁and 0.65869140625
▁energy 8.0859375
- 0.2198486328125
consum 0.35498046875
ing 0.018402099609375
. 0.728515625
<0x0A> 0.68994140625
Part 5.65625
icip 0.2366943359375
ants 0.1533203125
▁were 1.0107421875
▁rec 1.677734375
ru 0.01123809814453125
ited 0.0020961761474609375
▁for 1.40234375
▁six 1.0205078125
▁months 0.034576416015625
▁at 0.352294921875
▁two 0.1055908203125
▁major 0.2115478515625
▁pain 0.03643798828125
▁relief 0.0297088623046875
▁cent 0.0162811279296875
ers 0.0224151611328125
▁in 0.05975341796875
▁Israel 0.033294677734375
. 0.119140625
▁All 3.783203125
▁patients 1.7822265625
▁experienced 5.0
▁chron 1.6826171875
ic 0.004611968994140625
▁pain 0.09991455078125
▁for 3.2109375
▁at 0.97021484375
▁least 0.015350341796875
▁ 1.189453125
3 1.376953125
▁months 0.255615234375
. 0.978515625
▁The 1.62109375
▁study 1.82421875
▁included 2.232421875
▁ 1.1083984375
8 2.9140625
9 2.845703125
0 3.927734375
▁participants 1.505859375
, 1.26171875
▁of 1.7470703125
▁which 0.4150390625
▁ 0.1409912109375
4 1.703125
7 2.455078125
4 2.861328125
▁( 2.36328125
5 0.1455078125
9 10.328125
%) 0.994140625
▁were 0.51123046875
▁treated 4.51171875
▁sole 6.91015625
ly 0.00228118896484375
▁with 0.576171875
▁op 0.79931640625
io 0.395263671875
ids 0.199951171875
, 1.1328125
▁ 0.5595703125
3 1.123046875
2 2.119140625
9 2.51171875
▁( 0.062103271484375
4 1.025390625
1 1.197265625
%) 0.1429443359375
▁wer 9.0078125
▁treated 6.109375
▁with 0.199462890625
▁MM 1.15625
, 0.2122802734375
▁and 0.1746826171875
▁ 0.1456298828125
7 3.1328125
7 2.4375
▁( 0.236083984375
8 3.90234375
. 1.2197265625
6 2.697265625
%) 0.07305908203125
▁acquired 9.5390625
▁both 1.185546875
▁( 6.8359375
Fe 10.0390625
ing 3.53515625
old 0.036468505859375
▁et 1.431640625
▁al 0.08465576171875
., 0.408447265625
▁ 0.027740478515625
2 0.246337890625
0 0.004364013671875
1 0.5166015625
7 2.255859375
). 0.1431884765625
▁The 1.359375
▁remaining 7.01953125
▁ten 8.40625
▁participants 1.2724609375
▁who 5.1640625
▁did 1.5654296875
▁not 0.0214385986328125
▁r 9.21875
be 6.6328125
ce 7.48828125
ive 0.1932373046875
▁ph 3.447265625
arma 0.06842041015625
ce 0.00791168212890625
ut 0.0750732421875
ical 0.007659912109375
▁op 0.71435546875
io 0.093017578125
ids 0.03216552734375
▁and 1.9833984375
▁medical 1.728515625
▁mar 0.072509765625
iju 0.0474853515625
ana 0.004619598388671875
▁were 1.265625
▁with 6.0703125
dra 0.3212890625
wn 0.00626373291015625
▁from 0.300048828125
▁et 11.9609375
he 1.1435546875
▁analysis 4.7265625
▁in 5.06640625
▁the 1.330078125
▁research 4.296875
. 0.52392578125
▁Therefore 4.8359375
, 0.015838623046875
▁it 3.46875
▁is 0.8486328125
▁not 2.544921875
▁possible 0.78173828125
▁to 0.06768798828125
▁compreh 6.44140625
ens 0.1044921875
ively 0.07281494140625
▁compare 1.9013671875
▁Z 13.15625
pat 5.0625
ients 0.351318359375
▁taking 4.4921875
▁medic 3.998046875
ations 0.89501953125
▁with 1.5576171875
▁those 1.3076171875
▁who 1.251953125
▁do 2.1015625
▁not 0.0338134765625
. 0.73828125
<0x0A> 0.65478515625
The 1.2666015625
▁study 1.6279296875
▁conducted 4.62109375
▁a 2.58984375
▁correlation 6.28125
▁type 7.87109375
▁of 0.54443359375
▁research 2.26953125
▁with 2.884765625
▁variable 8.0859375
▁measures 4.50390625
. 1.2880859375
▁It 2.16015625
▁evaluated 4.57421875
▁the 0.63232421875
▁inter 5.8046875
dep 3.45703125
end 0.044097900390625
ence 0.039154052734375
▁of 0.54638671875
▁various 3.98046875
▁factors 1.8916015625
▁that 3.04296875
▁affected 4.33203125
▁the 0.671875
▁physical 6.796875
▁and 0.95654296875
▁emot 0.5947265625
ional 0.002197265625
▁condition 1.1279296875
▁of 0.1126708984375
▁patients 0.59033203125
▁experien 4.375
cing 0.0028514862060546875
▁chron 0.5673828125
ic 0.0016565322875976562
▁pain 0.02734375
. 0.235107421875
▁For 4.03125
▁example 1.4208984375
, 0.0211944580078125
▁the 1.2890625
▁survey 5.3828125
▁showed 3.1875
▁that 0.39892578125
▁the 1.8125
▁ratio 6.8671875
▁of 0.1634521484375
▁female 4.87890625
▁patients 0.7841796875
▁was 1.8857421875
▁remark 9.390625
ably 0.01038360595703125
▁higher 0.568359375
▁in 2.68359375
▁the 0.94921875
▁op 4.33203125
i 3.146484375
ates 0.437744140625
▁group 0.2841796875
▁compared 2.87890625
▁to 0.167236328125
▁the 0.46728515625
▁MM 0.7939453125
▁group 0.292724609375
. 0.5068359375
▁In 2.966796875
▁turn 4.36328125
, 0.00841522216796875
▁people 5.9453125
▁on 5.23828125
▁op 1.3623046875
i 0.630859375
ates 0.0123748779296875
▁were 1.1416015625
▁more 0.97021484375
▁likely 0.397216796875
▁to 0.077392578125
▁re 6.97265625
op 8.3515625
rt 3.23046875
▁major 7.12890625
▁de 0.9541015625
press 1.181640625
ive 0.0194091796875
▁dis 0.51025390625
orders 1.2412109375
. 1.6591796875
<0x0A> 2.671875
The 1.17578125
▁question 5.63671875
na 0.78271484375
ires 0.005435943603515625
▁used 2.0390625
▁different 8.9765625
▁variable 8.5546875
▁measures 0.83447265625
▁to 1.4501953125
▁collect 2.611328125
▁information 2.150390625
. 1.4482421875
▁For 2.05859375
▁example 0.231201171875
, 0.01052093505859375
▁it 4.01171875
▁included 2.619140625
▁compreh 8.703125
ensive 0.0278778076171875
▁os 12.2421875
cio 7.23828125
- 2.681640625
dem 4.48828125
ographic 0.09332275390625
▁data 1.2587890625
: 5.0
▁gender 1.8125
, 0.08929443359375
▁age 0.2177734375
, 0.076171875
▁country 4.4609375
, 1.3349609375
▁type 4.15234375
▁of 0.06787109375
▁residence 4.89453125
▁( 3.4921875
urban 2.17578125
/ 2.955078125
r 0.08740234375
ural 0.060516357421875
), 0.2274169921875
▁years 6.16015625
▁of 0.1663818359375
▁education 1.091796875
, 0.16455078125
▁and 1.900390625
▁employ 3.9921875
ment 0.015472412109375
▁status 0.417236328125
. 0.1842041015625
▁Pat 4.1875
ients 0.104736328125
▁were 1.263671875
▁also 0.89208984375
▁asked 0.61376953125
▁about 1.2626953125
▁their 0.6591796875
▁medical 2.875
▁history 0.56689453125
▁over 8.7734375
▁the 0.19140625
▁years 3.69140625
▁and 1.6826171875
▁the 1.8857421875
▁cur 10.65625
ent 1.5029296875
▁pres 4.375
l 12.0078125
ence 3.927734375
▁of 0.127197265625
▁any 3.693359375
▁severe 4.73828125
▁dise 1.73828125
as 5.859375
ers 5.484375
▁such 3.634765625
▁as 0.0458984375
▁heart 2.6953125
▁failure 2.337890625
, 0.2232666015625
▁di 1.96484375
ab 0.0143890380859375
etes 0.015777587890625
, 0.13134765625
▁ar 3.740234375
th 0.25
rit 0.0760498046875
is 0.042388916015625
, 0.0623779296875
▁and 1.5966796875
▁so 0.90869140625
▁on 0.044403076171875
. 0.04876708984375
▁The 1.775390625
▁third 7.43359375
▁measure 4.07421875
▁of 2.103515625
▁the 1.0947265625
▁question 2.330078125
naire 0.4912109375
▁was 0.7978515625
▁indicated 9.3203125
▁by 0.67724609375
▁information 6.87890625
▁on 1.6240234375
▁any 5.390625
▁twelve 13.453125
- 1.2041015625
month 0.487548828125
▁and 5.890625
▁lifetime 3.59375
▁drug 4.796875
▁and 3.6875
▁alco 0.1357421875
hol 0.01027679443359375
▁consumption 2.75
. 0.45361328125
▁In 3.525390625
▁ad 9.15625
pd 10.8125
ition 0.73193359375
, 0.41552734375
▁the 1.1572265625
▁record 8.3203125
▁inc 8.671875
ud 1.3232421875
ed 0.03790283203125
▁a 2.318359375
▁pain 6.13671875
▁measurement 4.1796875
▁scale 0.9736328125
▁fro 12.5234375
▁m 3.875
0 2.740234375
▁to 0.65625
▁ 0.08099365234375
1 0.0899658203125
0 0.1263427734375
▁to 4.30859375
▁evaluate 1.6943359375
▁dis 6.17578125
com 0.2301025390625
fort 0.04388427734375
▁feelings 6.8515625
▁during 3.44921875
▁the 0.9345703125
▁last 1.802734375
▁month 1.6337890625
. 0.3330078125
<0x0A> 0.94921875
Am 6.8046875
ong 0.07513427734375
▁all 2.25390625
▁participants 2.2109375
▁in 3.55859375
▁the 0.190673828125
▁study 0.436279296875
, 0.0672607421875
▁ 0.6806640625
4 1.83203125
2 2.802734375
. 1.779296875
2 2.283203125
% 0.1431884765625
▁suffered 4.89453125
▁from 0.1497802734375
▁de 1.98046875
pression 0.24169921875
, 1.1142578125
▁and 1.7568359375
▁ 0.1766357421875
3 1.7197265625
7 2.189453125
% 2.6171875
▁experienced 2.583984375
▁excess 7.41015625
ive 0.1400146484375
▁anx 0.255859375
ie 7.75
M 5.79296875
ty 6.171875
. 0.3330078125
▁The 1.4228515625
▁pl 10.6796875
ur 2.03515625
ality 0.00926971435546875
▁of 0.2137451171875
▁de 3.689453125
press 1.333984375
ive 0.12445068359375
▁dis 1.9052734375
orders 0.08819580078125
▁am 10.03125
z 5.0234375
ong 4.77734375
▁patients 1.45703125
▁in 4.11328125
▁the 0.347412109375
▁op 0.99609375
i 1.0634765625
ates 0.0214385986328125
, 5.46484375
▁medical 2.001953125
▁mar 0.0673828125
iju 0.1014404296875
ana 0.005481719970703125
, 0.06915283203125
▁and 0.0887451171875
▁mixed 5.2421875
▁OP 8.28125
MM 7.28125
▁groups 0.7314453125
▁number 11.2421875
ed 0.48974609375
▁ 0.1292724609375
5 2.12890625
7 2.482421875
. 0.2305908203125
1 2.349609375
%, 0.273193359375
▁ 0.013397216796875
2 2.88671875
2 2.44921875
. 0.08612060546875
3 2.26171875
%, 0.1337890625
▁and 0.051788330078125
▁ 0.0110931396484375
5 3.330078125
1 2.765625
. 0.17822265625
4 2.154296875
%, 0.4267578125
▁respectively 0.053497314453125
. 0.256103515625
▁The 1.4384765625
▁pl 4.58203125
ur 0.062042236328125
ality 0.00110626220703125
▁of 0.0648193359375
▁anx 0.99560546875
iety 0.1656494140625
▁contained 10.84375
▁ 0.80908203125
4 1.595703125
8 2.376953125
. 0.07659912109375
4 2.310546875
% 0.4541015625
▁among 1.923828125
▁OP 6.7890625
▁patients 9.4140625
, 0.28955078125
▁ 0.1077880859375
2 1.4892578125
1 2.421875
. 0.1387939453125
5 2.48046875
% 0.01396942138671875
▁among 0.41552734375
▁MM 0.363037109375
▁patients 0.247802734375
, 0.01367950439453125
▁and 0.0226898193359375
▁ 0.044403076171875
3 1.2939453125
8 2.66796875
. 0.151611328125
7 2.26953125
% 0.016448974609375
▁among 0.199462890625
▁OP 4.67578125
MM 0.501953125
▁participants 3.611328125
. 0.1968994140625
▁Pat 5.46875
ient 3.603515625
sw 9.9140625
ho 1.1201171875
▁took 2.765625
▁strong 8.3515625
▁op 1.01953125
i 1.6435546875
ates 0.019989013671875
▁were 1.8876953125
▁t 7.42578125
ended 1.875
▁to 0.046112060546875
▁la 9.8828125
ce 4.45703125
▁their 4.08203125
▁pain 2.849609375
▁on 6.05078125
▁a 1.0029296875
▁scale 3.49609375
▁of 0.55517578125
▁ 0.290283203125
9 3.564453125
▁to 1.3232421875
▁ 0.0293731689453125
1 0.042816162109375
0 0.1024169921875
▁( 2.736328125
Fe 1.9501953125
ing 0.03558349609375
old 0.01119232177734375
▁et 0.02716064453125
▁al 0.01194000244140625
., 0.014617919921875
▁ 0.0072021484375
2 0.001132965087890625
0 0.0014753341674804688
1 0.00421142578125
7 0.0236358642578125
). 0.061492919921875
▁They 4.81640625
▁were 1.3134765625
▁a 5.84375
T 8.2578125
l 5.28125
so 2.978515625
▁an 7.21875
gu 6.55078125
ise 7.36328125
hd 9.453125
▁em 7.23828125
otion 0.1387939453125
ally 0.0253448486328125
▁and 1.22265625
▁react 7.4765625
ed 0.1461181640625
▁rad 9.5234375
ically 0.2330322265625
▁neg 5.109375
atively 0.07659912109375
▁to 0.4140625
▁al 6.78125
mos 4.2734375
Qt 10.5
▁all 1.0908203125
▁survey 8.65625
▁questions 0.6728515625
. 0.333984375
▁Pat 4.33203125
ients 0.1156005859375
▁who 1.2216796875
▁took 1.267578125
▁only 5.65234375
▁MM 1.0244140625
▁or 3.326171875
▁mixed 3.8671875
▁medic 2.849609375
ations 0.369873046875
▁course 12.3515625
▁had 2.46875
▁a 1.2568359375
▁significantly 3.080078125
▁more 3.7578125
▁stable 3.287109375
▁emot 1.478515625
ional 0.0218963623046875
▁state 0.74853515625
▁and 1.4375
▁cop 5.5859375
ed 1.3779296875
▁with 0.82568359375
▁pain 1.6337890625
▁more 1.6357421875
▁manage 6.71875
able 2.708984375
. 0.55712890625
<0x0A> 0.60205078125
One 5.296875
▁of 0.63818359375
▁the 0.038421630859375
▁major 2.5390625
▁lim 9.25
ita 2.8984375
ions 1.3603515625
▁is 4.31640625
▁the 0.6416015625
▁ins 4.8515625
u 0.147705078125
fficient 0.1278076171875
l 9.1796875
▁high 11.015625
▁response 4.6953125
▁rate 0.284423828125
, 2.62890625
▁ 4.53515625
5 2.072265625
7 1.9453125
% 2.103515625
▁instead 7.9453125
▁of 0.03656005859375
▁ 0.7294921875
7 1.6611328125
0 1.6865234375
% 1.0400390625
▁( 2.095703125
Fe 0.428955078125
ing 0.0260009765625
old 0.009185791015625
▁et 0.00921630859375
▁al 0.01155853271484375
., 0.01251220703125
▁ 0.006122589111328125
2 0.0011320114135742188
0 0.00081634521484375
1 0.0031795501708984375
7 0.0149078369140625
). 0.047637939453125
▁It 2.791015625
▁can 3.10546875
▁be 0.3515625
▁fairly 8.7578125
▁explained 1.84765625
▁by 0.250244140625
▁the 0.32763671875
▁weak 8.203125
▁focus 7.00390625
▁of 0.455810546875
▁respond 6.3828125
ents 0.17138671875
▁who 3.306640625
▁have 4.2890625
▁overcome 8.15625
▁severe 2.375
▁pain 0.5732421875
▁es 12.09375
ns 10.046875
ations 5.54296875
▁and 1.48046875
▁de 5.01171875
press 1.751953125
ive 0.39404296875
▁episodes 4.75390625
. 0.6025390625
▁It 3.2890625
▁is 0.88720703125
▁not 2.4921875
▁clear 4.34375
▁how 1.650390625
▁to 3.66796875
▁use 5.390625
▁these 3.05078125
▁statistics 3.734375
, 2.66015625
▁as 1.2646484375
▁they 1.2646484375
▁still 6.37109375
▁may 4.80859375
▁be 1.3759765625
▁relevant 5.78125
▁for 1.3427734375
▁the 1.9248046875
▁overall 4.75390625
▁analysis 3.2890625
. 1.0126953125
